WHO ICTRP trial
Randomized, prospective, double-blind study to objectively demonstrate the…
DRKS00017381 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00017381 |
|---|---|
| Public title | Randomized, prospective, double-blind study to objectively demonstrate the performance and safety of the Rayocomp bioresonance device in patients with cervical spine disorder |
| Scientific title | Randomized, prospective, double-blind study to objectively demonstrate the performance and safety of the Rayocomp bioresonance device in patients with cervical spine disorder - R-HWS |
| Primary sponsor | Rayonex Biomedical GmbH |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 4 |
| Countries | Germany |
| Conditions | M54 M53;Dorsalgia;Other dorsopathies, not elsewhere classified |
| Interventions | Group 1: Treatment with the Rayocomp Bioresonance Device, 10 treatments over 21 days with acquisition of AE, demography, med. history at BL, determination of VAS, pain medication, 3 questionnaires - quality of life, performance, NID at BL… |
| Registration date | May 22, 2019 |
| Target size | 52 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: